Skip Navigation

Adalvo Partners with ADVANZ PHARMA

21 February 2023

Adalvo is pleased to announce that we have entered into a partnership with ADVANZ PHARMA, signing an exclusive licensing and supply agreement for a complex, specialty injectable generic for multiple European countries.

We are proud to be partnering with ADVANZ, and this agreement will complement their specialty and hospital portfolio nicely.

This partnership is another confirmatory step in ADVANZ’s strategy to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe. It also further enhances Adalvo's ability to offer differentiated, value-added products to our partners.